- Home
- CSTL vs PDS Comparison
CSTL vs PDS Comparison
Compare CSTL & PDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- PDS
- Stock Information
- Founded
- CSTL 2007
- PDS 1951
- Country
- CSTL United States
- PDS Canada
- Employees
- CSTL N/A
- PDS N/A
- Industry
- CSTL Medical Specialities
- PDS
- Sector
- CSTL Health Care
- PDS
- Exchange
- CSTL Nasdaq
- PDS Nasdaq
- Market Cap
- CSTL 697.9M
- PDS 764.8M
- IPO Year
- CSTL 2019
- PDS N/A
- Fundamental
- Price
- CSTL $22.75
- PDS $57.65
- Analyst Decision
- CSTL Strong Buy
- PDS Buy
- Analyst Count
- CSTL 6
- PDS 2
- Target Price
- CSTL $37.67
- PDS $87.00
- AVG Volume (30 Days)
- CSTL 348.6K
- PDS 74.4K
- Earning Date
- CSTL 11-03-2025
- PDS 10-22-2025
- Dividend Yield
- CSTL N/A
- PDS N/A
- EPS Growth
- CSTL N/A
- PDS N/A
- EPS
- CSTL N/A
- PDS 5.22
- Revenue
- CSTL $346,269,000.00
- PDS $1,355,177,217.00
- Revenue This Year
- CSTL N/A
- PDS N/A
- Revenue Next Year
- CSTL N/A
- PDS $1.37
- P/E Ratio
- CSTL N/A
- PDS $11.03
- Revenue Growth
- CSTL 20.40
- PDS N/A
- 52 Week Low
- CSTL $14.59
- PDS $36.20
- 52 Week High
- CSTL $35.84
- PDS $67.35
- Technical
- Relative Strength Index (RSI)
- CSTL 52.78
- PDS 53.19
- Support Level
- CSTL $22.28
- PDS $55.53
- Resistance Level
- CSTL $23.71
- PDS $59.11
- Average True Range (ATR)
- CSTL 1.05
- PDS 1.39
- MACD
- CSTL -0.12
- PDS -0.22
- Stochastic Oscillator
- CSTL 35.90
- PDS 45.76
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About PDS Precision Drilling Corporation
Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.